Sonnet Jonker, Ph.D., authors op-ed refuting claims that animal research is no longer necessary to ensure the safety of new drugs and that non-animal in vitro methods are sufficient.

In a story about the FDA Circulatory System Devices Panel advising that the benefits of the Endologix AFX2 stent graft systems should outweigh the risk in niche populations, panel member Joaquin Cigarroa, M.D., says: “I believe the type III endoleaks pose a challenge to patients, and I have not seen enough data to assure me with a degree of certainty that the problem no longer persists."

OHSU survey finds treatment programs hesitant to allow take-home methadone during the pandemic, despite loosening of federal regulations.

The OHSU forecasting document “employs a long-used epidemiological model to predict the number of persons who are susceptible to being infected, who are actively infected or who have recovered at any previous time. ..."

OHSU, other Portland metro health systems prepare for the rollout of COVID-19 vaccines for children ages 5 to 11.

Erick Gallun, Ph.D., is a fellow of the American Speech-Language-Hearing Association.

Michael Godsey, Ph.D., is among new members of the American Society for Biochemistry and Molecular Biology.

Allison Empey, M.D., co-authors the commentary, "Beyond “Red Man Syndrome”: A Case for American Indian Health Equity."

Pediatrician offices, OHSU and Kaiser Permanente officials told KOIN 6 News they will be holding special kid clinics to administer the doses. There will be an online registration for the young child doses.

A former employee has filed a lawsuit against OHSU alleging she was discriminated against after filing workers’ compensation claims related to COVID-19